Tirzepatide (10mg)

$119.95

Tirzepatide 10mg

Peptide is an innovative therapeutic option designed to tackle complex endocrinological and metabolic diseases, primarily focusing on the management of type 2 diabetes and supporting weight loss. This dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist uniquely integrates the actions of two incretin pathways, offering comprehensive metabolic benefits.

Product Description:

Tirzepatide is a synthetic peptide administered via subcutaneous injection, designed to enhance the body's natural ability to regulate blood sugar and insulin levels. Its distinct dual-target mechanism allows for superior efficacy in managing metabolic dysfunctions compared to existing monotherapies.

Key Benefits:

  1. Superior Glycemic Control: Tirzepatide provides a significant reduction in blood glucose levels by enhancing insulin secretion and decreasing glucagon release in a glucose-dependent manner. This dual-action supports better control over diabetes-induced blood sugar spikes.

  2. Substantial Weight Loss: The dual incretin receptor activity of Tirzepatide also aids in appetite suppression and promotes weight loss, benefiting patients with obesity or those needing significant weight management.

  3. Cardiovascular Protection: Beyond managing blood glucose and weight, Tirzepatide has shown potential in improving cardiovascular outcomes, contributing to a lower risk of heart-related events in patients with type 2 diabetes.

  4. Enhanced Insulin Sensitivity: The peptide improves the body's insulin sensitivity, making it easier to maintain normal blood glucose levels with less insulin.

  5. Simplicity in Treatment: With a convenient weekly dosing regimen, Tirzepatide simplifies the treatment protocol, enhancing adherence and improving quality of life for patients.

  6. Improvement in Lipid Profile: Tirzepatide may aid in improving patients' lipid profiles, reducing harmful cholesterol levels and supporting overall cardiovascular health.

Patients considering Tirzepatide should engage with healthcare providers to tailor the treatment to their individual health goals and conditions. Careful monitoring and personalized healthcare advice ensure optimal outcomes and minimize potential side effects.

FDA Disclaimer:
These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease. Always consult with a healthcare professional before starting any new supplement or treatment to ensure it is appropriate for your circumstances. This product should be used responsibly and in compliance with any applicable regulations or guidelines.

This designation allows the use of research chemicals strictly for in testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals.

CAS Number : 2023788-19-2

Product Format Solid in Solution

Molecular Formula C225 H348 N48 O68

Molecular Weight 4831

Purity >99.6% (HPLC)